quadraScope to present at the Foresight Institute Longevity Frontiers Workshop QUADSMaster February 2, 2023
Our portfolio company, Immunis, announced the first-in-human injection of its stem cell secretome product to treat age and disease-related immune decline QUADSMaster January 4, 2023
Nanoparticles to treat aging and age-related diseases – interview with Louis Hawthornes QUADSMaster December 27, 2022
The NIH awards the SenNet Consortium $190M to support senescent cell research. The capital comes from a $660M strategic fund reserved for projects with the potential to transform biomedical research. QUADSMaster December 23, 2022
Targeting the immune system to extend healthspan – interview with Dr. Hans Keirstead QUADSMaster November 25, 2022
quadraScope is nominated to join the Longevity Biotechnology Association QUADSMaster November 25, 2022
